Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters











Database
Language
Publication year range
1.
Pharm Res ; 28(4): 886-96, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21213024

ABSTRACT

PURPOSE: The influence of polymer architecture on cellular uptake and transport across Caco-2 cells of novel amphiphilic polyelectrolyte-insulin nanocomplexes was investigated. METHOD: Polyallylamine (PAA) (15 kDa) was grafted with palmitoyl chains (Pa) and subsequently modified with quaternary ammonium moieties (QPa). These two amphiphilic polyelectrolytes (APs) were tagged with rhodamine, and their uptake by Caco-2 cells or their polyelectrolyte complexes (PECs) with fluorescein isothiocyanate-insulin (FITC-insulin) uptake was investigated using fluorescence microscopy. The integrity of the monolayer was determined by measurement of transepithelial electrical resistance (TEER), and insulin transport across the monolayers was determined. RESULT: Pa and insulin were co-localised in cell membranes, while QPa complexes were found within the cytoplasm. QPa complex uptake was not affected by calcium, cytochalasin D or nocodazole. Uptake was reduced by co-incubation with sodium azide, an active transport inhibitor. Both polymers opened tight junctions reversibly, and insulin transport through monolayers increased when QPa or Pa was used. CONCLUSION: These APs have been shown to be taken up by Caco-2 cells and reversibly open tight cell junctions. Further work is required to optimise these formulations with a view to maximising their potential to facilitate oral delivery of insulin.


Subject(s)
Electrolytes/chemistry , Hypoglycemic Agents/administration & dosage , Insulin/administration & dosage , Nanoconjugates/chemistry , Surface-Active Agents/chemistry , Administration, Oral , Biological Transport , Caco-2 Cells , Cell Culture Techniques , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Humans , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/pharmacokinetics , Insulin/chemistry , Insulin/pharmacokinetics , Microscopy, Electron, Transmission , Microscopy, Fluorescence , Palmitic Acids/chemistry , Polyamines/chemistry , Succinimides/chemistry , Tromethamine/chemistry
2.
Fungal Genet Biol ; 45(10): 1404-14, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18765290

ABSTRACT

The outer layer of the Candida albicans cell wall is enriched in highly glycosylated proteins. The major class, the GlycosylPhosphatidylInositol (GPI)-anchored proteins are tethered to the wall by GPI-anchor remnants and include adhesins, glycosyltransferases, yapsins and superoxide dismutases. In silico analysis suggested that C. albicans possesses 115 putative GPI anchored proteins (GpiPs), almost twice the number reported for Saccharomyces cerevisiae. A global approach to characterise in silico predicted GpiPs has been initiated by generating a library of 45 mutants. This library was subjected to a screen for cell wall modifications by testing the cell wall integrity (SDS and Calcofluor White sensitivity) and response to caspofungin. We showed that, when caspofungin sensitivity was modified, in more than half of the cases the susceptibility can be correlated to the level of chitin and cell wall thickness: sensitive strains have low level of chitin and a thin cell wall. We also identified, for the first time, genes that when deleted lead to decreased caspofungin sensitivity: DFG5, PHR1, PGA4 and PGA62. The role of two unknown GpiPs, Pga31 and Pga62 in the cell wall structure and composition was clearly demonstrated during this study.


Subject(s)
Antifungal Agents/pharmacology , Candida albicans/drug effects , Candida albicans/metabolism , Cell Wall/drug effects , Cell Wall/metabolism , Echinocandins/pharmacology , Fungal Proteins/metabolism , Glycosylphosphatidylinositols/metabolism , Candida albicans/genetics , Caspofungin , Cell Wall/genetics , Chitin/metabolism , Fungal Proteins/genetics , Lipopeptides
3.
Fungal Genet Biol ; 45(6): 954-62, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18439859

ABSTRACT

The asexual multinucleated sporangia of Phytophthora infestans can germinate directly through a germ tube or indirectly by releasing zoospores. The molecular mechanisms controlling sporangial cytokinesis or sporangial cleavage, and zoospore release are largely unknown. Sporangial cleavage is initiated by a cold shock that eventually compartmentalizes single nuclei within each zoospore. Comparison of EST representation in different cDNA libraries revealed a putative ATP-dependent DEAD-box RNA-helicase gene in P. infestans, Pi-RNH1, which has a 140-fold increased expression level in young zoospores compared to uncleaved sporangia. RNA interference was employed to determine the role of Pi-RNH1 in zoospore development. Silencing efficiencies of up to 99% were achieved in some transiently-silenced lines. These Pi-RNH1-silenced lines produced large aberrant zoospores that had undergone partial cleavage and often had multiple flagella on their surface. Transmission electron microscopy revealed that cytoplasmic vesicles fused in the silenced lines, resulting in the formation of large vesicles. The Pi-RNH1-silenced zoospores were also sensitive to osmotic pressure and often ruptured upon release from the sporangia. These findings indicate that Pi-RNH1 has a major function in zoospore development and its potential role in cytokinesis is discussed.


Subject(s)
DEAD-box RNA Helicases/metabolism , Phytophthora/enzymology , Phytophthora/pathogenicity , Plant Diseases/parasitology , Spores/growth & development , Algal Proteins/chemistry , Algal Proteins/genetics , Algal Proteins/metabolism , Amino Acid Sequence , DEAD-box RNA Helicases/chemistry , DEAD-box RNA Helicases/genetics , Gene Silencing , Microscopy, Electron, Transmission , Molecular Sequence Data , Phenotype , Phylogeny , Phytophthora/genetics , Phytophthora/physiology , RNA Interference , Spores/enzymology , Spores/genetics , Spores/ultrastructure
4.
PLoS Pathog ; 4(4): e1000040, 2008 Apr 04.
Article in English | MEDLINE | ID: mdl-18389063

ABSTRACT

Echinocandins are a new generation of novel antifungal agent that inhibit cell wall beta(1,3)-glucan synthesis and are normally cidal for the human pathogen Candida albicans. Treatment of C. albicans with low levels of echinocandins stimulated chitin synthase (CHS) gene expression, increased Chs activity, elevated chitin content and reduced efficacy of these drugs. Elevation of chitin synthesis was mediated via the PKC, HOG, and Ca(2+)-calcineurin signalling pathways. Stimulation of Chs2p and Chs8p by activators of these pathways enabled cells to survive otherwise lethal concentrations of echinocandins, even in the absence of Chs3p and the normally essential Chs1p, which synthesize the chitinous septal ring and primary septum of the fungus. Under such conditions, a novel proximally offset septum was synthesized that restored the capacity for cell division, sustained the viability of the cell, and abrogated morphological and growth defects associated with echinocandin treatment and the chs mutations. These findings anticipate potential resistance mechanisms to echinocandins. However, echinocandins and chitin synthase inhibitors synergized strongly, highlighting the potential for combination therapies with greatly enhanced cidal activity.


Subject(s)
Antifungal Agents/pharmacology , Candida albicans/drug effects , Chitin Synthase/biosynthesis , Chitin/biosynthesis , Echinocandins/pharmacology , Enzyme Inhibitors/pharmacology , Gene Expression Regulation/drug effects , Benzenesulfonates/pharmacology , Calcium Chloride/pharmacology , Candida albicans/metabolism , Chitin Synthase/antagonists & inhibitors , Chitin Synthase/genetics , Dose-Response Relationship, Drug , Drug Antagonism , Drug Therapy, Combination , Enzyme Activators/pharmacology
5.
Invest Ophthalmol Vis Sci ; 46(11): 4260-6, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16249506

ABSTRACT

PURPOSE: This study evaluated the effect of transforming growth factor (TGF)-beta2 and anti-TGF-beta2 antibody in a rodent model of posterior capsule opacification (PCO). METHODS: An extracapsular lens extraction (ECLE) was performed in 72 Sprague-Dawley rats. At the end of the procedure, 10 microL TGF-beta2 (TGF-beta2-treated group), fetal calf serum (FCS)/phosphate-buffered saline (PBS; FCS/PBS-treated control group), a human monoclonal TGF-beta2 antibody (anti-TGF-beta2-treated group), or a null control IgG4 antibody (null antibody-treated control group) was injected into the capsule. Animals were killed 3 and 14 days postoperatively. Eyes were evaluated clinically prior to euthanatization, then enucleated and processed for light microscopy and immunohistochemistry afterward. PCO was evaluated clinically and histopathologically. Student's t-test and chi(2) were used to assess differences between groups. RESULTS: There were no statistically significant clinical or histopathological differences in degree of PCO between the TGF-beta2- and FCS/PBS-treated groups at 3 and 14 days after ECLE. Nor were there differences between the anti-TGF-beta2- and the null antibody-treated groups, with the exception of the histopathology score for capsule wrinkling 3 days after ECLE (P = 0.02). alpha-Smooth-muscle actin staining was observed in the lens capsular bag only in areas where there was close contact with the iris. CONCLUSIONS: No sustained effect of TGF-beta2 or anti-TGF-beta2 antibody on PCO was found in rodents at the dose and timing administered in this study. Iris cells may play a role in the process of epithelial mesenchymal transition linked to PCO.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Cataract/drug therapy , Disease Models, Animal , Lens Capsule, Crystalline/drug effects , Postoperative Complications , Transforming Growth Factor beta/immunology , Transforming Growth Factor beta/therapeutic use , Actins/metabolism , Animals , Cataract/etiology , Cataract/pathology , Immunoenzyme Techniques , Lens Capsule, Crystalline/metabolism , Lens Capsule, Crystalline/pathology , Male , Rats , Rats, Sprague-Dawley , Transforming Growth Factor beta2
6.
Arch Ophthalmol ; 123(1): 71-7, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15642815

ABSTRACT

OBJECTIVE: To present a new model of posterior capsule opacification (PCO) in mice. METHODS: An extracapsular lens extraction was performed in 28 consecutive mice. Animals were humanely killed 0 and 24 hours and 3 and 14 days after surgery. Eyes were enucleated and processed for light microscopy and immunohistochemistry. RESULTS: In 20 animals (71%), the eye appeared well healed before death. In 8 animals (29%), postoperative complications were noted. All animals developed PCO 2 weeks after surgery. Immediately after extracapsular lens extraction, lens epithelial cells were present in the inner surface of the anterior capsule and at the lens bow. At 24 hours, lens epithelial cells started to migrate toward the center of the posterior capsule. At 3 days, multilayered lens epithelial cells throughout the lens capsule and capsular wrinkling were apparent. Lens fibers and Soemmerring ring formation were observed 14 days after surgery. CD45(+) and CD11b (+) macrophages were found in greater numbers 24 hours and 3 days after surgery (CD45(+), P = .04 and P<.001, respectively; and CD11b(+), P = .01 and P = .004, respectively). The number of CD45(+) cells remained statistically significantly higher (P = .04) 14 days after surgery. CONCLUSION: In mice, PCO occurs following extracapsular lens extraction and is associated with low-grade but significant macrophage response. CLINICAL RELEVANCE: The use of genetically modified mice to evaluate the pathogenic mechanisms of PCO and search for new therapeutic modalities to prevent or treat PCO is now possible.


Subject(s)
Cataract/etiology , Disease Models, Animal , Lens Capsule, Crystalline/pathology , Postoperative Complications , Animals , CD11 Antigens/metabolism , Cataract/pathology , Cataract Extraction , Epithelial Cells/pathology , Immunohistochemistry , Lens, Crystalline/surgery , Leukocyte Common Antigens/metabolism , Macrophages/metabolism , Macrophages/pathology , Male , Mice , Mice, Inbred BALB C
7.
Biochem J ; 378(Pt 1): 247-55, 2004 Feb 15.
Article in English | MEDLINE | ID: mdl-14614769

ABSTRACT

The pro-apoptotic protein Bax plays a key role in the mitochondrial signalling pathway. Upon induction of apoptosis, Bax undergoes a conformational change and translocates to mitochondrial membranes, where it inserts and mediates the release of cytochrome c from the intermembrane space into the cytosol. However, the domains of Bax that are essential for the induction of cytochrome c release are still elusive. Therefore various Bax deletion mutants were generated and expressed in Escherichia coli. The proteins were then purified in order to delineate the function of the transmembrane domain, the BH3 (Bcl-2 homology 3) domain and the putative pore-forming alpha-helices-5 and -6. These proteins were used to analyse the mechanism of Bax-induced cytochrome c release from mitochondria. None of the Bax proteins caused cytochrome c release merely through physical perturbation of the mitochondrial outer membrane. The alpha-helices-5 and -6 of Bax were shown to mediate the insertion of the protein into mitochondrial membranes and to be essential for the cytochrome c -releasing activity of Bax. In contrast, neither the transmembrane domain nor a functional BH3 domain is required for the Bax-mediated release of cytochrome c from mitochondria.


Subject(s)
Cytochromes c/metabolism , Mitochondria/metabolism , Proto-Oncogene Proteins c-bcl-2 , Proto-Oncogene Proteins/chemistry , Animals , Female , Intracellular Membranes/metabolism , Membrane Potentials , Mice , Mitochondria/physiology , Mitochondria/ultrastructure , Mutation , Protein Structure, Secondary , Protein Structure, Tertiary , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/isolation & purification , Rats , bcl-2-Associated X Protein
8.
Invest Ophthalmol Vis Sci ; 44(8): 3450-7, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12882794

ABSTRACT

PURPOSE: To describe a new model of posterior capsule opacification (PCO) in rodents METHODS: An extracapsular lens extraction (ECLE), by continuous curvilinear capsulorrhexis and hydrodissection, was performed in 42 consecutive Brown Norway rats. Animals were killed at 0, 6, and 24 hours and 3, 7, and 14 days after surgery. Eyes were enucleated and processed for light microscopy and immunohistochemistry. RESULTS: In 34 (81%) of the animals the operated eye appeared well healed before death, with a clear cornea and a well-formed anterior chamber. In eight (19%) there was no view of anterior segment structures because of hyphema, fibrin, or corneal opacification. PCO was clinically evident 3 days after ECLE and was present in all animals at 2 weeks. Immediately after ECLE, lens epithelial cells (LECs) were present in the inner surface of the anterior capsule and lens bow. Twenty-four hours after surgery, LECs started to migrate toward the center of the posterior capsule. At 3 days, multilayered LECs, some spindle shaped, were present throughout the lens capsule. Capsular wrinkling was apparent. Lens fibers and Soemmering's ring were observed in all animals 14 days after surgery, indicating some degree of cellular differentiation. Activated macrophages were present in greater numbers at 3 and 14 days after surgery (P < 0.05), when proliferation and migration of LECs appeared to be greatest, and lens fiber differentiation was evident, respectively. CONCLUSIONS: In rodents PCO occurs after ECLE and is associated with low-grade inflammation, mostly of mononuclear macrophages. Although no intraocular lens implantation was performed, this model appears to be valuable for studying the sequence of events that leads to PCO after cataract surgery and the extracellular matrix cues that promote lens fiber differentiation.


Subject(s)
Cataract/pathology , Disease Models, Animal , Lens Capsule, Crystalline/pathology , Postoperative Complications/pathology , Animals , Biomarkers/analysis , Capsulorhexis , Cataract/metabolism , Cell Differentiation , Cell Division , Cell Movement , Epithelial Cells/metabolism , Epithelial Cells/pathology , Immunoenzyme Techniques , Lens Capsule, Crystalline/metabolism , Lens Capsule, Crystalline/surgery , Macrophages/pathology , Male , Postoperative Complications/metabolism , Rats , Rats, Inbred BN
SELECTION OF CITATIONS
SEARCH DETAIL